Global Health DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.77×	0.77×	0.74×	0.76×	0.73×
	0.98×	1.03×	0.95×	1.00×	0.97×
	15.6%	15.8%	18.5%	19.1%	17.2%
	0.83×	0.83×	0.81×	0.78×	0.74×
	1.48×	1.48×	1.41×	1.48×	1.70×
	14.5%	15.5%	14.9%	16.9%	15.2%
	15.2%	15.2%	15.3%	17.9%	16.1%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MEDANTA₹1,299.70

Global Health Ltd.

· Pharma & Health

₹ CrorePeersMAXHEALTH APOLLOHOSP FORTIS GLAXO ANTHEM AJANTPHARM IPCALAB ABBOTINDIAMcap ₹34,922 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.73	0.76	0.74	0.77	0.77
Interest Burden (Pretax/EBIT) ×	0.97	1.00	0.95	1.03	0.98
EBIT Margin %	17.16	19.12	18.51	15.79	15.64
Asset Turnover ×	0.74	0.78	0.81	0.83	0.83
Financial Leverage (Assets/Equity) ×	1.70	1.48	1.41	1.48	1.48
ROE (5-step product, year-end total equity) %	15.18	16.87	14.86	15.45	14.51
ROE (owners' profit / average owners' equity) %	16.13	17.93	15.30	15.15	15.15

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.